Global Immunoassays Market - Growth, Trends and Forecasts (2017 - 2022)

The global immunoassays market was estimated at USD 16,374.1 million in the year 2015 and is expected to reach USD 28,535.5 million by 2021, growing at a CAGR of 9.7% during the forecast period.

The global immunoassay market is expected to witness a good growth during the forecast period, due to the increasing incidences of infectious and chronic diseases. The rapid development of novel assays for detection of various autoimmune diseases such as oncology and cardiology, combined with the increasing use of immunoassays in drug discovery and toxicology testing, are also expected to further fuel the growth of immunoassay market during the forecast years. Furthermore, rising global demand for non-invasive diagnostic techniques and growing need for reagents, are further expected to boost the global immunoassay market.


Increasing spectrum of applications along with high sensitivity & specificity and cost effectiveness are the major driving factors for the growth of this market.


Social stigma concerns and lack of proper reimbursement policies are the main factors hindering the growth of the market.

The major factor that is hindering the adoption of immunoassays in the emerging markets is the need for refrigerated storage for the immunoassay kits and reagents. The companies that can develop immunoassay kits and reagents that can be stored at room temperature will see a huge growth in their revenues.

Market Segmentation

The global immunoassays market has been segmented based on technology (enzyme immunoassay, fluorescence immunoassay, chemiluminescence immunoassay, radio immunoassay, nephelometric immunoassay and others), by therapeutic area (cardiology, thyroid, autoimmune diseases, oncology, infectious diseases, hematology, allergies and others), by end users (hospitals, centralized laboratories, academic institutions, pharma & biotech firms, contract research organizations and others) and by geography (North America, Europe, APAC, Middle East and Africa, Latin America and Rest of the World).

Currently, North America is the largest market globally, followed by Europe; while APAC is the fastest growing segment. As per recent data, enzyme and fluorescence immunoassays account for the highest number of immunoassays performed, globally.

The report provides a detailed overview of each type of immunoassay, along with in-depth analysis and company profiles of major players in this space and a clear picture of a competitive landscape that currently exists in this market.

Some of the key players in the global immunoassays market include -

Abbott Laboratories, Inc.
Akers Biosciences, Inc.
Becton Dickinson and Company
Danaher Corporation (Beckman Coulter)
Devon Medical Products
EDP Biotech Corporation
Hologic (Gen-Probe)
Intrinsic LifeSciences
Key Deliverables

Market analysis for the global immunoassays market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the global immunoassays market.
Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped.
Related Topics: Global Molecular Diagnostics Market Growth, Trends and Forecasts (2017 - 2022)

1. Introduction

1.1 Study Deliverables

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and Forecast Period Years

1.6 General Study Assumptions

1.7 Report Description

2. Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric Forecast Model

2.4 Research Assumptions

3. Executive Summary

4. Key Inferences

5. Market Overview

5.1 Current Market Scenario

5.2 Porter?s Five Forces Analysis

5.2.1 Bargaining Power of Suppliers

5.2.2 Bargaining Power of Consumers

5.2.3 Threat of New Entrants

5.2.4 Threat of Substitute Products and Services

5.2.5 Competitive Rivalry Within the Industry

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

6.1 Market Drivers

6.1.1 Increasing Spectrum of Applications

6.1.2 High Sensitivity and Specificity

6.1.3 Cost Effectiveness

6.2 Market Restraints

6.2.1 Complicated and Cumbersome Regulatory Requirements

6.2.2 Low Adoption in Emerging Markets

6.2.3 Complicated and Cumbersome Assay Procedures

6.3 Key Challenges

6.3.1 Simplification of Assay Procedures

6.4 Current Opportunities in the Market

6.4.1 Room Temperature Stable Immunoassays

7. Market Segmentation

7.1 Global Immunoassays Market, by Technology

7.1.1 Enzyme Immunoassay

7.1.2 Fluorescence Immunoassay

7.1.3 Chemiluminescence Immunoassay

7.1.4 Radio Immunoassay

7.1.5 Nephelometric Immunoassay

7.1.6 Others

7.2 Global Immunoassays Market, by Therapeutic Area

7.2.1 Cardiology

7.2.2 Thyroid

7.2.3 Autoimmune Disease

7.2.4 Oncology

7.2.5 Infectious Diseases

7.2.6 Hematology

7.2.7 Allergies

7.2.8 Others

7.3 Global Immunoassays Market, by End Users

7.3.1 Hospitals

7.3.2 Centralized Laboratories

7.3.3 Academic Institutions

7.3.4 Pharma & Biotech Firms

7.3.5 Contract Research Organizations

7.3.6 Others

7.4 Global Immunoassays Market, by Geography

7.4.1 North America US Canada Mexico

7.4.2 Europe France UK Germany Italy Spain and Portugal Scandinavia Benelux Rest of Europe

7.4.3 Asia-Pacific India China Japan Australia & New Zealand South Korea Rest of Asia-Pacific

7.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa

7.4.5 Latin America Brazil Argentina Rest of Latin America

8. Competitive Landscape

8.1 Mergers & Acquisitions

8.2 Agreements, Collaborations and Partnerships

8.3 New Product Launches

9. Key Players

9.1 Abbott Laboratories, Inc

9.2 Akers Biosciences, Inc.

9.3 Becton Dickinson And Company

9.4 Biom?rieux

9.5 Danaher Corporation (Beckman Coulter)

9.6 Devon Medical Products

9.7 EDP Biotech Corporation

9.8 Hologic (Gen-Probe )

9.9 Intrinsic LifeSciences

9.10 Luminex Corporation

9.11 Meridian Life Science, Inc

9.12 Ortho Clinical Diagnostics/Jhonson & Jhonson

9.13 Qiagen

9.14 Roche Diagnostics Limited

9.15 Siemens Healthcare

9.16 Syntron Bioresearch, Inc.

9.17 Thermo Fisher Scientific, Inc/Bramhs

10. Future Outlook of the Market

Content are not available

Choose License Type